GlaxoSmithKline has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Huma...
Scientists have developed tiny Three-dimensional (3D) -printed scaffolds that can guide the regrowth of nerve cells, pos...
Chembio Diagnostics, Inc., a leader in point-of-care (POC) diagnostic testing, has announced a collaboration with the Fo...
Siemens Healthineers has introduced two new assays for quick diagnosis of acute myocardial infarction or heart attack, f...
Singapore- Merck, a leading science and technology company, announced that the German Federal Institute for Drugs and Me...
XLerateHealth, an enterprise-focused healthcare accelerator that helps early-stage healthcare companies has announced it...
Singapore- GlaxoSmithKline has made a $300 million equity investment in the Silicon Valley gene testing compan...
NanoSphere Health Sciences has been awarded a breakthrough patent, granting the biotech innovator full ownership over th...
Singapore - AstraZeneca has agreed to sell the European commercial rights to hypertension and heart...
Singapore - Biocept, a leading commercial provider of liquid biopsy tests designed to provide physicians with clin...
Tabula Rasa HealthCare, Inc., a healthcare technology company optimizing medication safety has announced a new generatio...
Singapore – The U.S. Food and Drug Administration approved Tibsovo (ivosidenib) tablets for the treatment of adult...
Singapore – The FDA approves Agios Pharmaceuticals' TIBSOVO (ivosidenib) for the treatment of adult pati...
Singapore –Bayer AG will no longer sell its controversial female contraceptive implant Essure after December 31. T...
Singapore – US Food and Drug Administration approves Pfizer’s Neupogen biosimilar Nivestym and is expected t...
Singapore – The U.S. Court of Appeals has affirmed the decision of the USPTO's Patent Trial and Appeal B...
Azafaros, a spin-off from Leiden University and Amsterdam UMC, focusing on the development of new therapies in the field...
The UK Government, last week, hosted the second in a series of roundtables with stakeholders from key life science busin...
